Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Diamandis

Showing results (501-510 of 787) with videos related to

Pageof 79
Sort By:
Clinical Biochemistry|November 4, 2009
Nidogen-2: a new serum biomarker for ovarian cancerCynthia Kuk, C Geeth Gunawardana, Antoninus Soosaipillai, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
Short tandem repeat polymorphism and cancer risk: influence of laboratory analysis on epidemiologic findingsNguyet Tran, Bupinder S Bharaj, Eleftherios P Diamandis, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 25, 2003
Are cardiovascular and sympathoadrenal effects of human "new pressor protein" preparations attributable to human coagulation beta-FXIIa?Peter C Papageorgiou, Ali Pourdjabbar, Akis A Amfilochiadis, et al.
British Journal of Cancer|May 3, 2002
Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancerA Chang, G M Yousef, A Scorilas, et al.
Cancer|March 26, 1999
Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinomaE P Diamandis, S I Helle, H Yu, et al.
Biochemical and Biophysical Research Communications|July 11, 2001
Identification and characterization of a novel human testis-specific kinase substrate gene which is downregulated in testicular tumorsA Scorilas, G M Yousef, K Jung, et al.
Cancer|March 15, 1995
Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinomaM A Levesque, D Katsaros, H Yu, et al.
Journal of Proteome Research|May 7, 2014
Integrating meta-analysis of microarray data and targeted proteomics for biomarker identification: application in breast cancerMaria P Pavlou, Apostolos Dimitromanolakis, Eduardo Martinez-Morillo, et al.
Clinical Proteomics|June 5, 2019
Elucidating the endogenous synovial fluid proteome and peptidome of inflammatory arthritis using label-free mass spectrometryShalini M Mahendran, Edward C Keystone, Roman J Krawetz, et al.
Cells|November 27, 2024
Does Incretin Agonism Have Sustainable Efficacy?Sok-Ja Janket, Miyo K Chatanaka, Dorsa Sohaei, et al.
Pageof 79

Showing results (501-510 of 787) with videos related to

Sort By:
Pageof 79
Clinical Biochemistry|November 4, 2009
Nidogen-2: a new serum biomarker for ovarian cancerCynthia Kuk, C Geeth Gunawardana, Antoninus Soosaipillai, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
Short tandem repeat polymorphism and cancer risk: influence of laboratory analysis on epidemiologic findingsNguyet Tran, Bupinder S Bharaj, Eleftherios P Diamandis, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 25, 2003
Are cardiovascular and sympathoadrenal effects of human "new pressor protein" preparations attributable to human coagulation beta-FXIIa?Peter C Papageorgiou, Ali Pourdjabbar, Akis A Amfilochiadis, et al.
British Journal of Cancer|May 3, 2002
Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancerA Chang, G M Yousef, A Scorilas, et al.
Cancer|March 26, 1999
Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinomaE P Diamandis, S I Helle, H Yu, et al.
Biochemical and Biophysical Research Communications|July 11, 2001
Identification and characterization of a novel human testis-specific kinase substrate gene which is downregulated in testicular tumorsA Scorilas, G M Yousef, K Jung, et al.
Cancer|March 15, 1995
Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinomaM A Levesque, D Katsaros, H Yu, et al.
Journal of Proteome Research|May 7, 2014
Integrating meta-analysis of microarray data and targeted proteomics for biomarker identification: application in breast cancerMaria P Pavlou, Apostolos Dimitromanolakis, Eduardo Martinez-Morillo, et al.
Clinical Proteomics|June 5, 2019
Elucidating the endogenous synovial fluid proteome and peptidome of inflammatory arthritis using label-free mass spectrometryShalini M Mahendran, Edward C Keystone, Roman J Krawetz, et al.
Cells|November 27, 2024
Does Incretin Agonism Have Sustainable Efficacy?Sok-Ja Janket, Miyo K Chatanaka, Dorsa Sohaei, et al.
Pageof 79